Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials

Joseph Fraiman et al.

Pfizer and Moderna mRNA COVID-19 vaccines were associated with an increased risk of serious adverse events of special interest, with an absolute risk increase of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95% CI -0.4 to 20.6 and -3.6 to 33.8), respectively. Combined, the mRNA vaccines were associated with an absolute risk increase of serious adverse events of special interest of 12.5 per 10,000 (95% CI 2.1 to 22.9). The excess risk of serious adverse events of special interest surpassed the risk reduction for COVID-19 hospitalization relative to the placebo group in both Pfizer and Moderna trials (2.3 and 6.4 per 10,000 participants, respectively).

Latest articles

Mike Stone Amazingly, it seems that this strive to be a better...
A Midwestern Doctor When you study the history of medicine, you will...
Meryl Nass and Michael Kane Executive Summary Informed consent is the basis...
Sasha Latypova I was asked to comment on the “bombshell” video released...
Christine Morgan Meridian Tapping or Meridian Tapping Techniques (MTT) are techniques that...
Nada Marković Namely, in the case of the autoimmune diseases, as a...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!